72606-054-01 : NDC 2026 Code

72606-054-01 : Omalizumab-igec ( Omlyclo )

Additionally :

You can get information about “72606-054-01” NDC code in 72606-054-01 in HTML format

HTML | 72606-054-01 in TXT (Plain Text) format

TXT | 72606-054-01 in PDF (Portable Document Format)

PDF | 72606-054-01 in XML format

XML formats.

NDC Code : 72606-054-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72606-054-01",
    "PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (72606-054-01)  / 2 mL in 1 SYRINGE, GLASS",
    "NDC11Code": "72606-0054-01",
    "ProductNDC": "72606-054",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Omlyclo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Omalizumab-igec",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20261005",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761399",
    "LabelerName": "CELLTRION USA, Inc.",
    "SubstanceName": "OMALIZUMAB",
    "StrengthNumber": "300",
    "StrengthUnit": "mg/2mL",
    "Pharm_Classes": "Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-10-10",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20261005",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}